The retina dose-area histogram: a metric for quantitatively comparing rival eye plaque treatment options
نویسنده
چکیده
PURPOSE Episcleral plaques have a history of over a half century in the delivery of radiation therapy to intraocular tumors such as choroidal melanoma. Although the tumor control rate is high, vision-impairing complications subsequent to treatment remain an issue. Notable, late complications are radiation retinopathy and maculopathy. The obvious way to reduce the risk of radiation damage to the retina is to conform the prescribed isodose surface to the tumor base and to reduce the dose delivered to the surrounding healthy retina, especially the macula. Using a fusion of fundus photography, ultrasound and CT images, tumor size, shape and location within the eye can be accurately simulated as part of the radiation planning process. In this work an adaptation of the dose-volume histogram (DVH), the retina dose-area histogram (RDAH) is introduced as a metric to help compare rival plaque designs and conformal treatment planning options with the goal of reducing radiation retinopathy. MATERIAL AND METHODS The RDAH is calculated by transforming a digitized fundus-photo collage of the tumor into a rasterized polar map of the retinal surface known as a retinal diagram (RD). The perimeter of the tumor base is digitized on the RD and its area computed. Area and radiation dose are calculated for every pixel in the RD. RESULTS The areal resolution of the RDAH is a function of the pixel resolution of the raster image used to display the RD and the number of polygon edges used to digitize the perimeter of the tumor base. A practical demonstration is presented. CONCLUSIONS The RDAH provides a quantitative metric by which episcleral plaque treatment plan options may be evaluated and compared in order to confirm adequate dosimetric coverage of the tumor and margin, and to help minimize dose to the macula and retina.
منابع مشابه
Monte Carlo Simulation for Treatment Planning Optimization of the COMS and USC Eye Plaques Using the MCNP4C Code
Introduction: Ophthalmic plaque radiotherapy using I-125 radioactive seeds in removable episcleral plaques is often used in management of ophthalmic tumors. Radioactive seeds are fixed in a gold bowl-shaped plaque and the plaque is sutured to the scleral surface corresponding to the base of the intraocular tumor. This treatment allows for a localized radiation dose delivery to the tumor with a ...
متن کاملبرآورد پارامترهای دوزیمتری پلاک های چشمی 106Ru/106Rh در براکی تراپی تومورهای ملانومای کوچک Uvea با استفاده از روش شبیه سازی مونت کارلو
Background and purpose: Concave eye applicators of Ru-106, a beta emitter source, have a lot of use in brachytherapy of intraocular tumors. This has led to the need of knowing the exact dose distribution caused by beta radiation to the tumor and its normal surrounding tissue. The purpose of this study was the 3D calculation of dose distribution for three Ru-106 plaques: CCA, CCB, and CGD in a h...
متن کاملDosimetric investigation of beta-emitting ophthalmic plaques for treatment of ocular tumors
Understanding the dose distribution of beta-emitting eye plaques respect to the location of tumor is of importance. In this study, the geometry of CCB, COB and CIB plaques (BEBIG manufacturer) for specific eye tumors were simulated and the effects of different coated radionuclides and plaque materials were investigated, by Geant4 simulation toolkit. For validation, a dosimetric investigation wa...
متن کاملSilastic Thickness Optimization in Uveal Melanoma Brachytherapy by Monte Carlo Method
Introduction In order to treat uveal Melanoma , first, radioactive seeds are laid on a silicone- made substance which is called Silastic after that they are inserted in the plaque, and finally, this plaque containing silicone-made substance is stitched to the sclera surface. The dose gradient within the tumor and healthy tissues can be varied due to changing the Silastic thickness between scler...
متن کاملBiological effects of ingested asbestos: report and commentary.
The concept of whole retina radiotherapy for infants and youngsters with retinoblastoma is not new. Such treatment was pioneered in the early 1960's shortly after the linear accelerator became available for medical use (Bagshaw & Kaplan, 1966). The linear accelerator provided the possibility of using focused small field megavoltage radiation beams to treat the entire retina while simultaneously...
متن کامل